Funding
← Back to your selection

IQ Capital

Activity from announced rounds

Activity in this selectionOct 17, 2026 · Sep 18, 2026
Rounds participated in
1
Confirmed lead rounds
1
All roles disclosed
New companies
1
First participation on record · 0 follow-on
Funding in participating rounds
$18M
1 disclosed · full round size, not this investor’s share

By stage

Seed1

By primary sector

Biotech1

By country

United Kingdom1

Rounds

1 in this selection
Undecimal Bio

Undecimal Bio develops delivery molecules that help RNA medicines reach specific tissues, with initial research programmes in kidney and vascular disease.

$18MSeed
Lead